Literature DB >> 9817528

Appearance of resistance to meropenem during the treatment of a patient with meningitis by Acinetobacter.

M L Núñez1, M C Martínez-Toldos, M Bru, E Simarro, M Segovia, J Ruiz.   

Abstract

A case is reported of a patient who developed Acinetobacter meningitis after an external ventricular drainage system had been fitted for control of intracranial pressure. During the process, nine strains of Acinetobacter isolated from her cerebrospinal fluid were indistinguishable by analysis of total genomic DNA by pulse-field gel electrophoresis. The first eight strains were sensitive to meropenem and imipenem (MICs < 1 g/l). The MIC of the last one, which had been recovered after 32 days during two courses of treatment with meropenem, increased to > 32 g/l for meropenem, while with imipenem the increase was minimal (MIC = 1.5 g/l). The microorganism persisted in the central nervous system despite the administration of different antimicrobials, including intraventricular aminoglycosides and six changes in the external ventricular system. The patient died 68 days after admission to the intensive care unit from bilateral cerebral ischemic lesions, intraventricular hemorrhage and cerebral edema with endocraneal hypertension, the Acinetobacter ventriculitis also contributing to this state.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9817528     DOI: 10.1080/00365549850160774

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  8 in total

1.  Evaluation of meropenem regimens suppressing emergence of resistance in Acinetobacter baumannii with human simulated exposure in an in vitro intravenous-infusion hollow-fiber infection model.

Authors:  Xin Li; Lin Wang; Xian-Jia Zhang; Yang Yang; Wei-Tao Gong; Bin Xu; Ying-Qun Zhu; Wei Liu
Journal:  Antimicrob Agents Chemother       Date:  2014-09-02       Impact factor: 5.191

2.  Treatment of Bacterial Meningitis.

Authors:  Allan R. Tunkel; W. Michael Scheld
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.725

Review 3.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 4.  Management of meningitis due to antibiotic-resistant Acinetobacter species.

Authors:  Baek-Nam Kim; Anton Y Peleg; Thomas P Lodise; Jeffrey Lipman; Jian Li; Roger Nation; David L Paterson
Journal:  Lancet Infect Dis       Date:  2009-04       Impact factor: 25.071

5.  Heteroresistance to meropenem in carbapenem-susceptible Acinetobacter baumannii.

Authors:  Alexandros Ikonomidis; Evangelia Neou; Vassiliki Gogou; Georgia Vrioni; Athanassios Tsakris; Spyros Pournaras
Journal:  J Clin Microbiol       Date:  2009-10-14       Impact factor: 5.948

Review 6.  Systematic Review of Efficacy, Pharmacokinetics, and Administration of Intraventricular Aminoglycosides in Adults.

Authors:  Marlys LeBras; Ivy Chow; Vincent H Mabasa; Mary H H Ensom
Journal:  Neurocrit Care       Date:  2016-12       Impact factor: 3.210

7.  Successful treatment of multicompartmental cerebral ventriculitis caused by Acinetobacter baumanii.

Authors:  Dom Mahoney; David Porter; Mahableshwar Albur
Journal:  IDCases       Date:  2017-11-21

Review 8.  Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter.

Authors:  Sameer Dhingra; Nor Azlina A Rahman; Ed Peile; Motiur Rahman; Massimo Sartelli; Mohamed Azmi Hassali; Tariqul Islam; Salequl Islam; Mainul Haque
Journal:  Front Public Health       Date:  2020-11-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.